Eaton Vance Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Eaton Vance Management’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,616	Closed	-$1.58M	–	1471
2020 Q3	$1.58M	Hold	11,616	–	–	﹤0.01%	894
2020 Q2	$1.12M	Hold	11,616	–	–	﹤0.01%	937
2020 Q1	$545K	Hold	11,616	–	–	﹤0.01%	1048
2019 Q4	$847K	Hold	11,616	–	–	﹤0.01%	1031
2019 Q3	$606K	Hold	11,616	–	–	﹤0.01%	1081
2019 Q2	$582K	Hold	11,616	–	–	﹤0.01%	1078
2019 Q1	$604K	Hold	11,616	–	–	﹤0.01%	1026
2018 Q4	$568K	Buy	+11,616	New	+$639K	﹤0.01%	974

Eaton Vance Management's MYOK Position: Q4 2020 in Review

Eaton Vance Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 11,616 shares — an estimated $1.58M sold.

Eaton Vance Management first reported a position in MYOK in Q4 2018 and held it in 8 quarters. The position peaked at $1.58M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Eaton Vance Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Eaton Vance Management sold 11,616 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $1.58M.
Eaton Vance Management first reported a position in MyoKardia, Inc. Common Stock in Q4 2018 and held it in 8 quarters.
Eaton Vance Management's MyoKardia, Inc. Common Stock position peaked at $1.58M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Eaton Vance Management's 13F filing for Q4 2020, filed 12 Feb 2021.